(Total Views: 535)
Posted On: 03/10/2022 6:31:30 PM
Post# of 148932
Quote:
Please explain why the FDA refuses to review ZYESAMI data until completion of a clinical trial.
Quite remarkable, they ask and answer their own question in one sentence. A better question is why the FDA has hindered trials by refusing to approve appropriate protocols.
(7)
(0)Scroll down for more posts ▼
